Real-World Evidence of First- or Second-Line Immune Checkpoint Inhibitors Versus Chemotherapy in Advanced NSCLC: A Prospective Pragmatic Multicenter Korean Study

JTO Clinical and Research Reports · Elsevier

Аннотация

Publication date: November 2026 Source: JTO Clinical and Research Reports, Volume 7, Issue 11 Author(s): Jinyong Kim, Sehhoon Park, Gyeong-Won Lee, Il-Hwan Kim, Dong-Wan Kim, Yun-Gyoo Lee, Jang Ho Cho, Eun-Kyung Cho, Hyun Woo Lee, Ji-Hyun Park, Eun Joo Kang, Youngjoo Lee, Nak-Hoon Son, So Hyeon Gwon, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn

Читать у издателя →

Похожие статьи